US Stock MarketDetailed Quotes

ALLR Allarity Therapeutics

Watchlist
  • 1.1000
  • -0.0100-0.90%
Close Nov 29 13:00 ET
  • 1.1100
  • +0.0100+0.91%
Post 16:26 ET
4.88MMarket Cap-156P/E (TTM)

Allarity Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Allarity Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Allarity Therapeutics Earnings Reports

  • Allarity Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 14 16:25 ET

  • Allarity Therapeutics | 8-K: Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights

    Nov 14 08:21 ET

  • Allarity Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 5 17:27 ET

  • Allarity Therapeutics | 8-K: Allarity Therapeutics Reports First Quarter Financial Results and Highlights, including Clear Clinical Benefits from Phase 2 Trial, NASDAQ Compliance, and Significant Improvement in Cash and Equity Balances

    May 15 09:20 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data